Charles J Dockendorff insider trades

Open-market stock purchases and sales by Charles J Dockendorff, Director at Hologic Inc, from SEC Form 4 filings since Jan 20, 2010.

Track record: 100% of 2 scored buys are up 5% or more since purchase, averaging +145%.

Recent trades

DateStockTradeValue
Apr 7, 2026HOLX Hologic IncSold (not open market)—
Apr 7, 2026HOLX Hologic IncSold (not open market)—
Apr 7, 2026HOLX Hologic IncSold (not open market)$356K
Apr 7, 2026HOLX Hologic IncSold (not open market)$233K
Apr 7, 2026HOLX Hologic IncSold (not open market)$305K
Apr 7, 2026HOLX Hologic IncSold (not open market)$347K
Apr 7, 2026HOLX Hologic IncSold (not open market)$359K
Apr 7, 2026HOLX Hologic IncSold (not open market)$372K
Apr 7, 2026HOLX Hologic IncSold (not open market)$330K
Apr 7, 2026HOLX Hologic IncSold (not open market)$346K
Mar 20, 2026KEYS Keysight Technologies, IncBought (not open market)—
Feb 26, 2026HOLX Hologic IncBought (not open market)—

Companies traded

  • HOLX Hologic Inc: 1 buy, 2 sales, last Apr 7, 2026
  • KEYS Keysight Technologies, Inc: 1 buy, 1 sale, last Mar 20, 2026
  • HAE Haemonetics Corp: 2 sales, last Jul 24, 2025
  • BSX Boston Scientific Corp: 1 buy, 2 sales, last May 9, 2024
  • COV Covidien plc: 1 buy, 9 sales, last Jan 26, 2015

Get free alerts when Charles J Dockendorff files a new trade →